Bioinformatics strategies for translating genome-wide expression analyses into clinically useful cancer markers

被引:44
作者
Rhodes, DR
Chinnaiyan, AM
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Pathol Microarray Lab, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
来源
APPLICATIONS OF BIOINFORMATICS IN CANCER DETECTION | 2004年 / 1020卷
关键词
cancer; biomarkers; bioinformatics; meta-analysis; microarray;
D O I
10.1196/annals.1310.005
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The DNA microarray has revolutionized cancer research. Now, scientists can obtain a genome-wide perspective of cancer gene expression. One potential application of this technology is the discovery of novel cancer biomarkers for more accurate diagnosis and prognosis, and potentially for the earlier detection of disease or the monitoring of treatment effectiveness. Because microarray experiments generate a tremendous amount of data and because the number of laboratories generating microarray data is rapidly growing, new bioinformatics strategies that promote the maximum utilization of such data are necessary. Here, we describe a method to validate multiple microarray data sets, a Web-based cancer microarray database for biomarker discovery, and methods for integrating gene ontology annotations with microarray data to improve candidate biomarker selection.
引用
收藏
页码:32 / 40
页数:9
相关论文
共 18 条
[1]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[2]   Minimum information about a microarray experiment (MIAME) - toward standards for microarray data [J].
Brazma, A ;
Hingamp, P ;
Quackenbush, J ;
Sherlock, G ;
Spellman, P ;
Stoeckert, C ;
Aach, J ;
Ansorge, W ;
Ball, CA ;
Causton, HC ;
Gaasterland, T ;
Glenisson, P ;
Holstege, FCP ;
Kim, IF ;
Markowitz, V ;
Matese, JC ;
Parkinson, H ;
Robinson, A ;
Sarkans, U ;
Schulze-Kremer, S ;
Stewart, J ;
Taylor, R ;
Vilo, J ;
Vingron, M .
NATURE GENETICS, 2001, 29 (04) :365-371
[3]   ArrayExpress - a public repository for microarray gene expression data at the EBI [J].
Brazma, A ;
Parkinson, H ;
Sarkans, U ;
Shojatalab, M ;
Vilo, J ;
Abeygunawardena, N ;
Holloway, E ;
Kapushesky, M ;
Kemmeren, P ;
Lara, GG ;
Oezcimen, A ;
Rocca-Serra, P ;
Sansone, SA .
NUCLEIC ACIDS RESEARCH, 2003, 31 (01) :68-71
[4]   Delineation of prognostic biomarkers in prostate cancer [J].
Dhanasekaran, SM ;
Barrette, TR ;
Ghosh, D ;
Shah, R ;
Varambally, S ;
Kurachi, K ;
Pienta, KJ ;
Rubin, MA ;
Chinnaiyan, AM .
NATURE, 2001, 412 (6849) :822-826
[5]   Gene Expression Omnibus: NCBI gene expression and hybridization array data repository [J].
Edgar, R ;
Domrachev, M ;
Lash, AE .
NUCLEIC ACIDS RESEARCH, 2002, 30 (01) :207-210
[6]  
Luo J, 2001, CANCER RES, V61, P4683
[7]  
Magee JA, 2001, CANCER RES, V61, P5692
[8]   Prostasin, a potential serum marker for ovarian cancer: Identification through microarray technology [J].
Mok, SC ;
Chao, J ;
Skates, S ;
Wong, KK ;
Yiu, GK ;
Muto, MG ;
Berkowitz, RS ;
Cramer, DW .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (19) :1458-1464
[9]   Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer [J].
Rhodes, DR ;
Sanda, MG ;
Otte, AP ;
Chinnaiyan, AM ;
Rubin, MA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (09) :661-668
[10]  
Rhodes DR, 2002, CANCER RES, V62, P4427